14.09.2017 • News

Air Products in China Syngas Project

(c) cbpix/Shutterstock
(c) cbpix/Shutterstock

US industrial gases group Air Products has signed an agreement with Lu’An Clean Energy, part of Chinese coal mining conglomerate Lu’An Mining, to form a $1.3 billion joint venture for a syngas-to-liquids complex at Changzhi City in Shanxi province.

Air Products will contribute four air separation units (ASUs) that it previously constructed to supply the site as well as $500 million in cash for a majority 60% stake in the new company, which will be called Air Products Lu’An (Changzhi) Co. The industrial gases group has already invested $300 million to build, own and operate the ASUs.

Lu’An, which will contribute the gasification and syngas purification system, will receive $500 million and take a 40% share in the venture.

Under terms of the deal, Lu’An will supply coal, steam and power to the jv, which in turn will provide syngas under a long-term, onsite contract to Lu’An Mining for the production of a reported 1.8 million t/y of liquid fuels (mainly diesel) and chemicals.

Air Products’ chairman, president and CEO, Seifi Ghasemi, said the venture is “perfectly in line with our stated strategy of deploying our significant cash to grow by acquiring existing assets and expanding our scope of supply to include syngas.”

Li Jinping, chairman of Lu’An, added: “Extending our strong partnership/relationship with Air Products through this new joint venture enables us to take advantage of world-leading project management and operational expertise to deliver syngas for this landmark energy project.”

The transaction is expected to close as soon as possible, pending government and regulatory approvals and initial operational start-up. Financial details were not disclosed.

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.